May 11, 2017 by Chain Drug Review
Biotechnology Innovation Organization, commissioner of the Food and Drug Administration, FDA commissioner, Food and Drug Administration, Jim Greenwood, Lamar Alexander, Robert Califf, Scott Gottlieb, Stephen Ostroff, Tom Price, U.S. Department of Health and Human Services
Featured Articles, Leading Headlines, Pharmacy, Retail News

WASHINGTON — Dr. Scott Gottlieb has been sworn in as the new commissioner of the Food and Drug Administration. Gottlieb, nominated as FDA commissioner by President Donald Trump in March, took the helm as the FDA’s 23rd commissioner on Thursday after being confirmed by a vote of 57-42 in the Senate late Tuesday. He takes
August 31, 2016 by Chain Drug Review
benzodiazepines, FDA, Food and Drug Administration, opioid analgesic misuse, opioid analgesics, prescription opioid cough products, Robert Califf
Featured Articles, Leading Headlines, Pharmacy, Retail News

SILVER SPRING, Md. — Citing dangers from combined use, the Food and Drug Administration is requiring classwide changes to labeling for opioid analgesics, prescription opioid cough products and benzodiazepines, a group of central nervous system depressant drugs. The FDA said Wednesday that the changes mandate boxed warnings — the agency’s strongest warning — and patient
July 8, 2016 by Chain Drug Review
Alex Gourlay, Brad Fluegel, FDA, Food and Drug Administration, National Institutes of Health, next-generation sequencing, Precision Medicine Initiative, Precision Medicine Initiative Cohort Program, Robert Califf, Walgreens, Walgreens Boots Alliance
Leading Headlines, Pharmacy, Retail News

DEERFIELD, Ill. — Walgreens plans to participate in the U.S. Precision Medicine Initiative Cohort Program, part of a sweeping federal medical research initiative to help develop individualized care based on a person’s genomic makeup. Walgreens said it’s taking part in the PMI Cohort Program via an initial $20 million grant awarded to The Scripps Research
February 24, 2016 by Chain Drug Review
FDA, FDA commissioner, Food and Drug Administration, Margaret Hamburg, Robert Califf, Stephen Ostroff, Sylvia Burwell
Leading Headlines, Pharmacy, Retail News

WASHINGTON — The U.S. Senate overwhelmingly confirmed Dr. Robert Califf as commissioner of the Food and Drug Administration. Califf, who was deputy commissioner for medical products and tobacco, was nominated as FDA commissioner by President Barack Obama in mid-September. No significant opposition was expected for his confirmation hearing on Tuesday, as the Senate voted 89-4
September 28, 2015 by Brian Bossetta and Chain Drug Review
Food and Drug Administration, Robert Califf, Stephen Ostroff
2015, Issue 09-28-2015, Issues, News
WASHINGTON — The Food and Drug Administration’s current deputy commissioner for medical products and tobacco is likely to become the organization’s next commissioner. Dr. Robert Califf, a cardiologist and clinical researcher long affiliated with Duke University, was nominated by President Obama earlier this month to head up the FDA. Though Califf must face Senate confirmation
September 16, 2015 by Chain Drug Review
Barack Obama, FDA commissioner, Food and Drug Administration, Margaret Hamburg, Robert Califf, Stephen Ostroff
Leading Headlines, Pharmacy, Retail News

WASHINGTON — The Food and Drug Administration’s current deputy commissioner for medical products and tobacco is likely to become the organization’s next commissioner. Dr. Robert Califf, a cardiologist and clinical researcher long affiliated with Duke University, on Tuesday was nominated as FDA commissioner by President Barack Obama. On Wednesday, his nomination was sent to the